Codexis Publishes FY2023 Sustainability Disclosures

Core Insights - Codexis, Inc. has published its first sustainability disclosures, detailing its environmental, social, and governance (ESG) performance for the fiscal year ending December 31, 2023, aligning with IFRS SASB guidance [1] - The company aims to enhance its sustainability performance and reporting as it continues to grow as a partner in sustainable drug manufacturing [2] Company Overview - Codexis is a leading enzyme engineering company utilizing its proprietary CodeEvolver® technology platform to develop high-performance enzymes and proteins [3] - The company is focused on addressing challenges in small molecule pharmaceuticals manufacturing and nucleic acid synthesis, and is developing the ECO Synthesis™ platform for RNAi therapeutics [3] - Codexis' enzymes contribute to higher yields, reduced energy usage, lower waste generation, and improved efficiency in manufacturing and diagnostic applications [3]